Tag Archives: cvd

Why You Can’t Miss The Medical Education Convergence Weekend

The 2022 Medical Education Convergence (MEC) Weekend is a three-day educational experience designed to connect leading minds and influential voices in healthcare. Gathering experts from a range of medical specialties – from psychoneuroimmunology to pediatric nutrition – and game-changing educational programs, this event provides unparalleled learning and networking opportunities.

Taking place at the stunning Terranea Resort in Rancho Palos Verdes, CA, between September 8-10, 2022, MEC Weekend offers more than just professional development. Hosted on a luxurious property offering breathtaking views of the Pacific Ocean, 102 acres of lush grounds, and a suite of amenities, the event venue is a reason to attend in itself.

California is the perfect place to kick off a new academic season with sun-filled days and outdoor activities abound, immersed in the nature of the coast. The event brings together the best of both worlds, a relaxing end-of-summer getaway with cutting-edge educational programming. Featuring the inaugural Pediatric Brain and Resilience SummitNavigate Aging: Telomere Biology and Longevity SummitPeptide Therapy Masterclass, and the bestselling Module XVI-A: Advanced Cardiovascular Health – the MEC weekend will be a monumental event.

Read on to discover some innovative programs and topics we are most excited about.

Continue reading

Where Our Worlds Collide: The Systemic Storm of Inflammation, Cardiovascular Disease and Psoriasis 

A Partner Blog from Three of the Tarsus Family of Brands: American Academy of Anti-Aging Medicine, Cardiometabolic Health Congress, and LiVDerm.

A review published in May 2021 in the European Cardiology Review sought to elucidate the various potential factors, mechanisms, or processes linking cardiovascular disease (CVD) and psoriasis. Observational relationships between these two diseases include: an increased independent association between cardiovascular disease and severe psoriasis in younger patients; a higher mortality rate in patients with psoriasis with an overall five-year reduction in life expectancy; a parallel rise in psoriasis severity and CVD risk factors such as hypertension, diabetes, hyperlipidemia, and nonalcoholic fatty liver disease; a higher rate of both CVD and psoriasis in geographical populations furthest from the equator; and the majority of deaths in patients with psoriasis being attributed to cardiovascular or cerebrovascular events. The authors of the review noted that severe psoriasis was more strongly linked to cardiovascular-related mortality than was mild or moderate psoriasis.

Continue reading